Accrol Group Holdings PLC Update on Health and Safety Incident (1775C)
January 17 2018 - 10:25AM
UK Regulatory
TIDMACRL
RNS Number : 1775C
Accrol Group Holdings PLC
17 January 2018
The information contained within this announcement is deemed by
the Company to constitute inside information stipulated under the
Market Abuse Regulation (EU) No. 596/2014. Upon the publication of
this announcement via the Regulatory Information Service, this
inside information is now considered to be in the public
domain.
17 January 2018
Accrol Group Holdings plc
(the "Company")
Update on Health and Safety Incident
Further to the Update on Health & Safety Incident
announcement made by Accrol Group Holdings plc (AIM:ACRL) on 12
October 2017, the Company announces that, at the sentencing hearing
today, Accrol Papers Limited (a directly owned subsidiary of the
Company) was fined GBP120,000 (after discount) for a single health
and safety regulatory offence.
The sentencing court commented that the fine had been reduced by
one third in light of the guilty plea entered at the earliest
opportunity and the Company's full co-operation with the HSE
investigation. The Company has been given 12 months to pay the
fine.
As previously reported, the Health & Safety Executive (HSE)
had previously indicated to the Company that it was seeking a fine
in the range of GBP550,000 to GBP2.9m for this incident.
Accrol takes the Health and Safety of its employees very
seriously and the directors are pleased that this has been
recognised in today's judgement.
For further information,
please contact:
Accrol Group Holdings plc Tel: +44 (0) 1254 278844
Gareth Jenkins, Chief Executive
Officer
Zeus Capital Limited (Nominated
Adviser & Broker)
Dan Bate / Andrew Jones Tel: +44 (0) 161 831
1512
Dominic King / John Goold Tel: +44 (0) 203 829
5000
Belvedere Communications Tel: +44 (0) 20 3567
Limited 0510
Cat Valentine cvalentine@belvederepr.com
John West jwest@belvederepr.com
Kim Van Beeck kvbeeck@belvederepr.com
Notes to Editors
Accrol Group Holdings plc, based in Lancashire, is a leading
tissue converter and supplier of toilet rolls, kitchen rolls and
facial tissues as well as other tissue products to the UK's largest
retailers.
Accrol operates from three sites:
-- a manufacturing, storage and distribution facility in Blackburn;
-- a facial tissue plant, also in Blackburn; and
-- a manufacturing, storage and distribution facility in Leyland.
In addition, the business has a 368,000 sq ft storage and
distribution facility in Skelmersdale, Lancashire.
Accrol manufactures approximately 18 million units per week,
supplying customers with both Accrol branded and "private label"
products.
This information is provided by RNS
The company news service from the London Stock Exchange
END
ARILLFFELVIDLIT
(END) Dow Jones Newswires
January 17, 2018 10:25 ET (15:25 GMT)
Accrol (LSE:ACRL)
Historical Stock Chart
From Apr 2024 to May 2024
Accrol (LSE:ACRL)
Historical Stock Chart
From May 2023 to May 2024